Overview
Description
Odi Pharma AB is a company involved in the pharmaceutical industry, focusing on the cultivation, production, and distribution of cannabis-based products. The company operates primarily to take advantage of the growing demand for medical cannabis products by ensuring high-quality standards in its cultivation and processing facilities. Odi Pharma AB aims to deliver reliable and effective cannabis-derived medicinal solutions to markets across Europe, complying with the stringent regulatory requirements of the pharmaceutical sector. The company's operations have made significant impacts on the healthcare and biotechnology sectors, offering alternatives for pain management and therapeutic treatments. As the demand for pharmaceutical-grade cannabis continues to rise, Odi Pharma AB plays a critical role in expanding its market presence and contributing to medical advancements.
About
CEO
Mr. Jan-Mark Edewaard
Employees
1
Address
Oestermalmstorg 1
Stockholm, 114 42
Stockholm, 114 42
Phone
—
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Sweden
MIC code
XSTO